Organometallics
Article
31.1 (CH2−COD), 30.1 (CH2−COD), 28.7 (CH2−COD), 21.2 (CH3),
21.2 (CH3), 17.6 (CH3). FT-IR in KBr (cm−1): 3432, 2926, 2873,
2830, 2348, 1601, 1495, 1453, 1236, 1177, 1152, 1074, 1032, 856,
753. Found: C, 50.13; H, 5.25; N, 6.77. Calcd for C27H32IN3ORh: C,
50.33; H, 5.01; N, 6.52.
CH2−COD). 13C NMR (CDCl3, 100 MHz) δ = 171.7 (d, J = 44.1 Hz,
CRh), 171.7 (d, J = 45.4 Hz, CRh), 171.5 (d, J = 45.9 Hz, C
Rh), 171.5 (d, J = 46.0 Hz, CRh), 141.9 (Ctz), 141.9 (Ctz), 139.9
(Cmes), 136.2 (Cmes), 136.0 (Cmes), 134.6 (Cmes), 134.5 (Cmes), 129.8
(CHmes), 128.8 (Cmes), 128.4 (CHmes), 94.2 (CHCOD), 93.5
(CHCOD), 93.4 (CHCOD), 72.6 (CHCOD), 72.5 (CHCOD), 70.8
Complex 3b. Following the procedure for the synthesis of complex
3a and using rhodium(I) cyclooctadiene chloride dimer (31.0 mg,
0.063 mmol), potassium hexamethyl disilazide (32.0 mg, 0.164
mmol), and bistriazolium salt 2b (50.0 mg, 0.063 mmol), the title
product is purified by column chromatography using a mixture of
hexanes/ethyl acetate (8:2) as eluent. Yellow solid, 72% yield (55 mg,
(CH2−C ), 70.6 (CH2−Cpent), 66.1 (CH2), 66.0 (CH2), 46.9
pent
(Cpent), 38.2 (NCH3), 38.1 (NCH3), 34.3 (CH2−COD), 30.7
(CH2−COD), 30.5 (CH2−COD), 28.7 (CH2−COD), 28.6 (CH2−COD),
28.1 (CH2−COD), 21.3 (CH3), 21.2 (CH3), 18.0 (CH3), 18.0 (CH3).
Found: C, 45.32; H, 5.37; N, 7.02. Calcd for C89H120I4N12O4Rh4: C,
45.70; H, 5.08; N, 7.19. FT-IR in KBr (cm−1): 3446, 2916, 2872,
2823, 1614, 1447, 1326, 1262, 1153, 1072, 1030, 956, 853, 799. [ESI-
MS, positive mode]: M+ = 2340.6 m/z; [M+ − I]+ 2213.6 m/z.
General Synthesis of Carbonylated Complexes 4a−c.
Carbon monoxide was bubbled for 15 min to a solution of the
appropriate [Rh(COD)Cl]-triazolylidene (0.05 mmol) in 10 mL of
CH2Cl2. The light-orange solution turned slightly yellow. The solvent
was removed under vacuum, and the residue was washed thrice with 5
mL of petroleum ether to produce the pure carbonylated complex.
Complex 4a. Yellow solid, 89% yield (0.0445 mmol). Mp = 238−
240 °C. 1H NMR (CDCl3, 400 MHz) δ = 7.36−7.31 (m, 2H, CHar),
7.14−7.10 (m, 2H, CHar), 7.05−7.01 (m, 1H, CHar), 6.99 (s, 2H,
CHmes), 5.54 (s, 2H, CH2), 4.27 (s, 3H, NCH3), 2.37 (s, 3H, CH3),
2.03 (s, 6H, CH3). 13C NMR (CDCl3, 100 MHz) δ = 187.1 (d, J =
52.7 Hz, Rh−CO), 182.2 (d, J = 77.3 Hz, Rh−CO), 165.8 (d, J = 38.8
Hz, CRh), 157.0 (Car), 143.2 (Ctz), 143.2 (Ctz), 140.8 (Cmes),
135.7 (Cmes), 134.7 (Cmes), 129.8 (CHar), 129.4 (CHmes), 122.2
(CHar), 115.3 (CHar), 62.0 (CH2), 37.8 (NCH3), 21.3 (CH3), 18.6
(CH3). FT-IR in KBr (cm−1): 3444,2919, 2850, 2052 (CO), 1983
(CO), 1598, 1586, 1487, 1462, 1231, 1169, 1078, 1034, 1016,
1014, 861, 845. Found: C, 42.77; H, 3.89; N, 7.51. Calcd for
C21H21IN3O3Rh: C, 42.52; H, 3.57; N, 7.08.
1
0.045 mmol). Mp = 163−166 °C. H NMR (CDCl3, 400 MHz) δ =
7.39 (t, J = 8.16, 1H, CHar), 7.08 (s, 2H, CHmes), 6.94 (s, 2H, CHmes),
6.93−6.88 (m, 3H, CHar), 6.34−6.28 (m, 2H, CH2), 5.25−5.17 (m,
2H, CH2), 5.13−5.05 (m, 2H, CHCOD), 5.02−4.95 (m, 2H, CHCOD),
4.22−4.17 (m, 6H, NCH3), 4.76−4.68 (m, 2H, CHCOD), 3.18−3.10
(m, 2H, CHCOD), 2.46 (s, 6H, 2CH3), 2.39 (s, 6H, 2CH3), 2.19−2.09
(m, 2H, CH2−COD), 2.07−1.95 (m, 4H, CH2−COD), 1.88−1.74 (m,
8H, CH3 + CH2−COD), 1.69−1.55 (m, 4H, CH2−COD), 1.54−1.45 (m,
2H, CH2−COD), 1.43−1.33 (m, 2H, CH2−COD). 13C NMR (CDCl3,
100 MHz) δ = 172.3 (d, J = 45.7 Hz, CRh), 172.2 (d, J = 45.7 Hz,
CRh), 158.3 (Car), 139.9 (Ctrz), 130.0 (Cmes), 135.2 (Cmes), 134.8
(Cmes), 133.5 (Cmes), 129.5 (CHar), 128.7 (CHmes), 127.2 (CHmes),
107.1 (CHar), 101.9 (CHar), 101.8 (CHar), 93.3 (CHCOD),93.3
(CHCOD), 93.2 (CHCOD), 93.2 (CHCOD), 93.0 (CHCOD), 93.0
(CHCOD), 92.9 (CHCOD), 92.9 (CHCOD), 71.9 (CHCOD), 71.8
(CHCOD), 69.9 (CHCOD), 69.8 (CHCOD), 62.1 (s, CH2), 36.1
(NCH3), 32.6 (CH2−COD), 29.9 (CH2−COD), 29.2 (CH2−COD), 27.6
(CH2−COD), 20.1 (CH3), 16.7 (CH3). FT-IR in KBr (cm−1): 3446,
2923, 2364, 2059, 1606, 1446, 1382, 1330, 1283, 1236, 1156, 1132,
1035, 908, 850, 760. Found: C, 47.41; H, 4.66; N, 6.69. Calcd for
C48H59I2N6O2Rh2: C, 47.58; H, 4.91; N, 6.94.
Complex 3c. Following the procedure for the synthesis of complex
3a and using rhodium(I) cyclooctadiene chloride dimer (32.0 mg,
0.065 mmol), potassium hexamethyl disilazide (34.0 mg, 0.169
mmol), and tristriazolium salt 2c (50.0 mg, 0.043 mmol), the title
product is purified by column chromatography using a mixture of
dichloromethane/ethanol (95:5) as eluent. Yellow solid, 65% yield
Complex 4b. Yellow solid, 99% yield (0.0498 mmol). Mp = 236−
1
238 °C. H NMR (CDCl3, 400 MHz) δ = 7.27 (t, J = 8.3 Hz, 1H,
CHar), 6.99 (s, 4H, CHmes), 6.88 (t, J = 2.3 Hz, 1H, CHar), 6.80 (dd, J
= 8.3, 2.4 Hz, 2H, CHar), 5.51 (s, 4H, CH2), 4.29 (s, 6H, NCH3),
2.37 (s, 6H, CH3), 2.03 (s, 12H, CH3). 13C NMR (CDCl3, 100 MHz)
δ = 187.1 (d, J = 52.7 Hz, Rh−CO), 182.2 (d, J = 77.4 Hz, Rh−CO),
165.8 (d, J = 38.9 Hz, CRh), 158.5 (Car), 143.0 (Ctz), 143.0 (Ctz),
140.9 (Cmes), 135.7 (Cmes), 134.8 (Cmes), 130.6 (CHar), 129.5
(CHmes), 108.5 (CHar), 103.2 (CHar), 62.1 (CH2), 37.8 (NCH3),
21.4 (CH3), 18.7 (CH3). FT-IR in KBr (cm−1): 3450, 2924, 2850,
2066 (CO), 1992 (CO), 1599, 1489, 1450,1328, 1248, 1180,
1147, 1031, 850. Found: C, 39.31; H, 3.52; N, 7.30. Calcd for
C36H36I2N6O6Rh2: C, 39.01; H, 3.27; N, 7.58.
1
(50 mg, 0.028 mmol). Mp = 250−252 °C. H NMR (CDCl3, 400
MHz) δ = 7.02 (s, 3H, CHmes), 6.89 (s, 3H, CHmes), 6.62−6.55 (m,
3H, CHar) 6.32−6.22 (m, 3H, CH2), 5.15−5.08 (m, 3H, CH2), 5.03−
4.96 (m, 3H, CHCOD), 4.95−4.89 (m, 3H, CHCOD), 4.16 (s, 9H,
NCH3), 3.75−3.68 (m, 3H, CH2−COD), 3.13−3.05 (m, 3H,
CH2−COD), 2.40 (s, 9H, CH3), 2.33 (s, 9H, CH3), 2.15−2.05 (m,
3H, CH2−COD), 1.98−1.88 (m, 6H0, CH2−COD), 1.83−1.68 (m, 12H,
CH3 + CH2−COD), 1.60−1.50 (m, 6H, CH2−COD), 1.47−1.38 (m, 3H,
CH2−COD), 1.37−1.28 (m, 3H, CH2−COD). 13C NMR (CDCl3, 100
MHz) δ = 173.5 (d, J = 45.5 Hz, CRh), 173.4 (d, J = 45.6 Hz, C
Rh), 173.3 (d, J = 45.5 Hz, CRh), 160.4 (Car), 140.8 (Ctz), 140.1
(Cmes), 136.2 (Cmes), 135.9 (Cmes), 134.7 (Cmes), 129.8 (CHmes),
128.4 (CHmes), 95.4 (CHar), 95.3 (CHar), 94.3 (CHCOD), 94.2
(CHCOD), 73.3 (CHCOD), 73.2 (CHCOD), 63.0 (CH2), 37.3 (NCH3),
33.9 (CH2−COD), 30.9 (CH2−COD), 30.4 (CH2−COD), 28.6
(CH2−COD), 21.3 (CH3), 18.1 (CH3), 18.0 (CH3). Found: C,
46.51; H, 5.12; N, 7.24. Calcd for C70H90I3N9O3Rh3: C, 46.84; H,
5.05; N, 7.02. FT-IR in KBr (cm−1): 3433, 2916, 2372, 2172, 1605,
1439, 1377, 1329, 1245, 1159, 1042, 854. [ESI-MS, positive mode]:
M+ = 1794.9 m/z; [M+ − I]+ 1669.9 m/z.
Complex 4c. Yellow solid, 80% yield (0.040 mmol). Mp = 233−
1
234 °C. H NMR (CDCl3, 400 MHz) δ = 6.99 (s, 6H, CHmes), 6.57
(s, 3H, CHar), 5.49 (s, 6H, CH2), 4.30 (s, 9H, NCH3), 2.37 (s, 9H,
CH3), 2.04 (s, 18H, CH3). 13C NMR (CDCl3, 100 MHz) δ = 187.2
(d, J = 52.6 Hz, Rh−CO), 182.1 (d, J = 77.2 Hz, Rh−CO), 165.6 (d, J
= 38.9 Hz, CRh), 159.4 (Car), 142.8 (Ctz), 142.8 (Ctz), 140.9
(Cmes), 135.7 (Cmes), 134.7 (Cmes), 129.4 (CHmes), 96.2 (CHar), 62.1
(CH2), 37.9 (NCH3), 21.3 (CH3), 18.7 (CH3). Found: C, 38.56; H,
3.42; N, 7.88. Calcd for C52H54I3N9O9Rh3: C, 38.12; H, 3.32; N, 7.69.
FT-IR in KBr (cm−1): 3450, 2924, 2855, 2176, 2067 (CO), 1995
(CO), 1951, 1605, 1453, 1378, 1330, 1252, 1155, 1036, 851.
[MALDI-TOF MS, positive mode], M+ = 1623.4529 m/z; [M+
5CO]+ = 1479.977 m/z.
−
Complex 3d. Following the procedure for the synthesis of complex
3a and using rhodium(I) cyclooctadiene chloride dimer (33.0 mg,
0.066 mmol), potassium hexamethyl disilazide (34.0 mg, 0.173
mmol), and tetratriazolium salt 2d (50.0 mg, 0.033 mmol), the title
product is purified by precipitation with petroleum ether. Yellow
solid, 69% yield (54 mg, 0.023 mmol). Mp = 260−261 °C. 1H NMR
(CDCl3, 400 MHz) δ = 6.99 (s, 4H, CHmes), 6.86 (s, 4H, CHmes),
5.08−5.37 (m, 8H, CH2), 4.92 (s, 8H, CHCOD), 4.25−4.10 (m, 12H,
NCH3), 3.95−3.80 (m, 8H, CH2), 3.54 (s, 4H, CHCOD), 3.02 (s, 4H,
CHCOD), 2.37 (s, 12H, CH3), 2.31 (s, 12H, CH3), 2.27−2.15 (m, 4H,
CH2−COD), 2.05−1.90 (m, 8H, CH2−COD), 1.77−1−67 (m, 16H, CH3
+ CH2−COD), 1.66−1.57 (m, 4H, CH2−COD), 1.42−1.25 (m, 8H,
Complex 4d. Yellow solid, 99% yield (0.0498 mmol). Mp = 218−
1
220 °C. H NMR (CDCl3, 400 MHz) δ = 6.98 (s, 8H, CHmes), 5.58
(s, 8H, CH2), 4.31 (s, 12H, NCH3), 3.76 (s, 8H, CH2), 2.36 (s, 12H,
CH3), 2.07 (s, 24H, CH3). 13C NMR (CDCl3, 100 MHz) δ = 187.1
(d, J = 52.5 Hz, Rh−CO), 182.3 (d, J = 77.4 Hz, Rh−CO), 164.2 (d, J
= 38.7 Hz, CRh), 143.6 (d, J = 2.0 Hz, Ctz), 140.8 (Cmes), 135.7
(Cmes), 134.7 (Cmes), 129.5 (CHmes), 70.3 (CH2), 64.6 (CH2), 38.3
(NCH3), 21.3 (CH3), 18.8 (CH3). Found: C, 36.05; H, 3.64; N, 8.02.
Calcd for C65H72I4N12O12Rh4: C, 36.61; H, 3.41; N, 7.88. FT-IR in
KBr (cm−1): 3453, 2922, 2855, 2064 (CO), 1992 (CO), 1607,
H
Organometallics XXXX, XXX, XXX−XXX